Johnson & Johnson (JNJ) Gains from Investment Securities (2009 - 2026)

Johnson & Johnson has disclosed Gains from Investment Securities across 18 years of filings, most recently posting $54.0 million for Q1 2026.

• Gains from Investment Securities for Q1 2026 came in at $54.0 million, up 80.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $186.0 million (down 6.53% YoY), and the FY2025 annual result was $162.0 million, down 6.9% from the prior year.
• Gains from Investment Securities came in at $54.0 million for Q1 2026 at Johnson & Johnson, down from $63.0 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $111.0 million in Q4 2023 to a low of -$185.0 million in Q1 2023.
• The 5-year median for Gains from Investment Securities is $33.0 million (2025), against an average of $16.8 million.
• Across the five-year window, Gains from Investment Securities sank 85.59% in 2024 and soared 500.0% in 2025, its largest moves.
• Johnson & Johnson's Gains from Investment Securities stood at $59.0 million in 2022, then slumped by 276.27% to -$104.0 million in 2023, then surged by 169.23% to $72.0 million in 2024, then declined by 12.5% to $63.0 million in 2025, then fell by 14.29% to $54.0 million in 2026.
• The last three Gains from Investment Securities figures came in at $54.0 million (Q1 2026), $63.0 million (Q4 2025), and $33.0 million (Q3 2025), per Business Quant data.